DrugPatentWatch Database Preview

PANTOPRAZOLE SODIUM Drug Profile

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Pantoprazole Sodium patents expire, and what generic alternatives are available?

Pantoprazole Sodium is a drug marketed by Akorn Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Sandoz Inc, Exela Pharma Scs Llc, Actavis Totowa, Amneal Pharms, Apotex Inc, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Jubilant Generics, Lannett Co Inc, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Perrigo R And D, Sun Pharm Inds Ltd, Teva, Torrent Pharms, and Wockhardt. and is included in twenty-two NDAs.

The generic ingredient in PANTOPRAZOLE SODIUM is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Sixty-three suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the pantoprazole sodium profile page.

Summary for PANTOPRAZOLE SODIUM

US Patents:	0
Applicants:	20
NDAs:	22
Suppliers / Packagers:	59
Bulk Api Vendors:	98
Clinical Trials:	21
Patent Applications:	2,298
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for PANTOPRAZOLE SODIUM
DailyMed Link:	PANTOPRAZOLE SODIUM at DailyMed

Pharmacology for PANTOPRAZOLE SODIUM

Drug Class	Proton Pump Inhibitor
Mechanism of Action	Proton Pump Inhibitors

Synonyms for PANTOPRAZOLE SODIUM

(-)-Pantoprazole

102625-70-7

138786-67-1

142678-35-1

1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-

1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, sodiums salt

1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-,sodium salt

1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-

1H-Benzimidazole, 6-(difluoromethoxy)-2-((S)-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-

3B1-001838

5- -2-(( -1H-benzimidazolesodium

5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole sodium

5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole

5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole

5-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1h-benzo[d]imidazole, sodium salt

5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole

5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole

5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-3H-1,3-benzodiazole

5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole

5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Sodium Salt

5-(DIFLUOROMETHOXY)-2-[[(3,4-DIMETHOXY-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZIMIDAZOLE(Sodium salt form)

5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole

5-Difluoromethoxy-2-(3,4-dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole

5-DifluoroMethoxy-2-[(3,4-diMethoxy-2-pyridinyl)Methyl-sulfinyl]-1H-benziMidazole

5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole

6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole

6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole

6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole

6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole

6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole

6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Sodium Salt

6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole

6-[bis(fluoranyl)methoxy]-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole

625P707

A800593

AB0000909

AB0012612

AB01275513_02

AB01275513-01

AB2000509

AC-679

AC1L1IPJ

ACT02633

AK326135

AKOS015894910

AKOS015994677

Ambap138786-67-1

AN-15599

Anagastra

API0003746

apo-Pantoprazole

Apton

Astropan

Astropan (TN)

B-8510-29

B-8610-23/SK&F-96022-Z

B4720

BC203892

BC215353

BDBM50241342

BIDD:GT0003

BRD-A22380646-001-01-5

BSPBio_002320

BY 1023

BY-1023

BY-1023 sodium

By-1023/SK&F-96022

C11806

C16H14F2N3NaO4S

C16H15F2N3O4S

C16H16F2N3O4S.Na

CAS-102625-70-7

CAS-138786-67-1

CCG-100980

CCG-213558

CHEBI:50270

CHEBI:7915

CHEMBL1200408

CHEMBL1502

Citrel

Controloc

Controloc (TN)

Controloc Control

CPD000469592

CS-3161

CTK8E8734

D05353

D0T6XX

DB00213

DR002178

DSSTox_CID_24215

DSSTox_CID_3416

DSSTox_GSID_23416

DSSTox_GSID_44215

DSSTox_RID_77019

DSSTox_RID_80123

DTXSID4023416

DTXSID7044215

DZ-2352a

FT-0602547

FT-0602602

GTPL7260

HE067074

HE116877

HE290793

HMS1922H20

HMS2051L19

HMS2090H03

HMS2093F14

HMS3393L19

HSDB 7292

HY-17507

I06-0068

Inipomp

Inipomp (TN)

IQPSEEYGBUAQFF-UHFFFAOYSA-N

J-000744

J-516336

J10399

KB-303064

KS-00000GVT

KS-1093

L-Pantoprazole

LS-32883

LS-32884

MCULE-8988409059

MFCD00870182

MLS001424073

MLS003882559

MolPort-003-666-752

MolPort-005-933-577

MolPort-006-069-204

MolPort-006-823-953

NC00230

NCGC00095188-01

NCGC00095188-02

NCGC00095188-03

NCGC00095188-04

NCGC00095188-05

NCGC00255835-01

Nolpaza

NSC-759257

NSC759257

Pantecta

Pantecta (TN)

Pantecta Control

Pantoloc

Pantoloc (TN)

Pantoloc Control

Pantopan (TN)

Pantoprazol

Pantoprazol [INN-Spanish]

pantoprazole

Pantoprazole (Protonix)

Pantoprazole (USAN/INN)

Pantoprazole [USAN:BAN:INN]

Pantoprazole [USAN:INN:BAN]

Pantoprazole Na

Pantoprazole Sodium [USAN]

Pantoprazole sodium hydrate

PANTOPRAZOLE SODIUM SALT

Pantoprazole sodium sesquihydrate

Pantoprazole sodium;

Pantoprazole-d6 (Rac)

Pantoprazole, S-

Pantoprazolum

Pantoprazolum [INN-Latin]

Pantoprozole

Pantor

Pantor (TN)

Pantorc

Pantotab (TN)

Pantozol

Pantozol (TN)

Pantozol Control

Peptazol

Pharmakon1600-01505818

Protium

Protium (TN)

Protonix

Protonix (TN)

Protonix I.V

Protonix I.V.

Protonix IV

Rifun

RT-014935

S-(-)-Pantoprazole

s2105

s4538

S86P671

SAM001246591

SBB070993

SBI-0206873.P001

SC-19214

SCHEMBL29465

SCHEMBL3543

SK-96022

SK&F 96022

SK&F-96022

SKF-96022

SKF96022 sodium

SMR000469592

SMR002533625

sodium 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole

Sodium 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide

sodium 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazol-1-ide

sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sesquihydrate

sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide

SODIUM PANTOPRAZOLE(1-)

Sodium-[5(difluoromethoxy)-2-[[3,4-dimethoxy-2-pyridyl)-methyl]sulfinyl]-1H-benzimidazole sesquihydrate

sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide

Somac

Somac (TN)

Somac Control

SPECTRUM1505818

STL451032

SX78SGO2TV

TL8000127

Tox21_111477

Tox21_111477_1

Tox21_112996

Tox21_302362

Ulcepraz (TN)

Ulcotenal

UNII-SX78SGO2TV

W-1227

YNWDKZIIWCEDEE-UHFFFAOYSA-N

Zosecta

Zurcal

US Patents and Regulatory Information for PANTOPRAZOLE SODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Ltd	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	200794-002	May 2, 2012		DISCN	No	No
Perrigo R And D	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	203024-001	May 7, 2014	AB	RX	No	No
Teva	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	077056-001	Aug 2, 2007	AB	RX	No	No
Sun Pharm Inds Ltd	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	077058-001	Sep 10, 2007		DISCN	No	No

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans